Малайзия - английский - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - neisseria meningitides,group w-135 polysaccaride; neisseria meningitides,group c polysaccharide; neisseria meningitides,group a polysaccharide; neisseria meningitides,group y polysaccharide -

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - outer membrane vesicles (omv) from neisseria meningitidis group b containing the pora p1.4; neisseria meningitidis group b nhba fusion protein; neisseria meningitidis group b nada protein; neisseria meningitidis group b fhbp fusion protein - suspension for injection

Сингапур - английский - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - intended for the identification of frequently isolated neisseria and haemophilus as well as several other fastidious bacteria.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid);  ; neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) - injection with diluent - 0.5 ml - active: haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid)   neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) excipient: sodium chloride sucrose tetanus toxoid trometamol hydrochloride sodium chloride water for injection - menitorix is indicated for the prevention of invasive diseases caused by haemophilus influenzae type b (hib) and neisseria meningitidis serogroup c (menc).

Ирландия - английский - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - conjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus; conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1) - powder and solvent for solution for injection - 0.5 millilitre(s) - hemophilus influenzae b, combinations with meningococcus c, conjugated

Европейский союз - английский - EMA (European Medicines Agency)

sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,

Сингапур - английский - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - is recommended for use in slide agglutination tests for serotyping neisseria meningitidis

Сингапур - английский - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - the bd probetec™ neisseria gonorrhoeae qx amplified dna assay, when tested with the bd viper lt™ system, uses strand displacement amplification technology for the direct, qualitative detection of neisseria gonorrhoeae dna in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens (both upt and neat). the assay is also intended for use with gynecological specimens collected in bd surepath™ preservative fluid or preservcyt™ solution using an aliquot that is removed prior to processing for either the bd surepath or thinprep™ pap test. the assay is indicated for use with asymptomatic and symptomatic individuals to aid in the diagnosis of gonococcal urogenital disease.

Мальта - английский - Medicines Authority

pfizer healthcare ireland - neisseria meningitidis polysaccharide group c 10 µg, aluminium 10 µg, corynebacterium diphtheriae crm197 carrier protein 10 µg - suspension for injection

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

wyeth pharmaceuticals - neisseria meningitidis group c capsular polysaccharide protein conjugate - suspension for injection